ivacaftor
Showing 1 - 25 of 46
Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects
Completed
- Cystic Fibrosis
- Ivacaftor
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 10, 2022
Cystic Fibrosis Trial in Worldwide (Ivacaftor)
Active, not recruiting
- Cystic Fibrosis
- Ivacaftor
-
Birmingham, Alabama
- +28 more
Sep 14, 2022
Cystic Fibrosis Trial in Worldwide (ivacaftor)
Active, not recruiting
- Cystic Fibrosis
- ivacaftor
-
Birmingham, Alabama
- +22 more
Feb 4, 2022
COPD Trial (Ivacaftor)
Withdrawn
- Chronic Obstructive Pulmonary Disease
- Ivacaftor
- (no location specified)
Jan 11, 2022
Cystic Fibrosis Trial in United States (Tezacaftor/Ivacaftor, Ivacaftor, Tezacaftor/Ivacaftor matching )
Primary Ciliary Dyskinesia Trial in Worldwide (VX-371, Hypertonic Saline, Placebo (0.17% saline))
Cystic Fibrosis Trial in Australia, Germany, Israel (ELX-02, Ivacaftor)
Recruiting
- Cystic Fibrosis
- ELX-02
- Ivacaftor
-
Camperdown, New South Whales, Australia
- +8 more
Feb 15, 2022
Cystic Fibrosis Trial in San Francisco (ivacaftor, Placebo)
Completed
- Cystic Fibrosis
- ivacaftor
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2020
Cystic Fibrosis Trial in Jerusalem (Ivacaftor, Placebo)
Completed
- Cystic Fibrosis
- Ivacaftor
- Placebo
-
Jerusalem, IsraelHadassah Medical Organization
Feb 13, 2020
Cystic Fibrosis Selected Gating Mutations onCFTR Allele
Completed
- Cystic Fibrosis
- ivacaftor
-
Bari, Italy
- +14 more
Nov 12, 2020
Cystic Fibrosis Trial in Australia (Tezacaftor/Ivacaftor, Ivacaftor, Placebo)
Cystic Fibrosis Trial in Stanford (Ivacaftor, ß-Adrenergic cocktail, Pilocarpine Nitrate 5%)
Completed
- Cystic Fibrosis
- Ivacaftor
- +3 more
-
Stanford, CaliforniaStanford Hospital and Clinics
Dec 21, 2018
Cystic Fibrosis Trial in France, Germany, United States (Tezacaftor/Ivacaftor, Ivacaftor, Placebo)
Cystic Fibrosis Trial in Worldwide (Ivacaftor, Tezacaftor/Ivacaftor)
Cystic Fibrosis Trial in Australia, Canada, United Kingdom (ivacaftor, Placebo)
Terminated
- Cystic Fibrosis
- ivacaftor
- Placebo
-
Parkville, Victoria, Australia
- +5 more
Oct 20, 2018
Cystic Fibrosis Trial in Worldwide (VX-661 plus ivacaftor combination, Ivacaftor, Placebo (matched to VX-661 plus ivacaftor
Completed
- Cystic Fibrosis
- VX-661 plus ivacaftor combination
- +3 more
-
Birmingham, Alabama
- +42 more
May 8, 2018
Cystic Fibrosis Trial in Worldwide (VX-661/Ivacaftor, Ivacaftor, Placebo matched to VX-661/ ivacaftor)
Cystic Fibrosis Trial in Worldwide (VX-661 Plus Ivacaftor Combination, Ivacaftor, VX-661 Plus Ivacaftor Combination Placebo)
Completed
- Cystic Fibrosis
- VX-661 Plus Ivacaftor Combination
- +3 more
-
Little Rock, Arkansas
- +74 more
May 8, 2018
Cystic Fibrosis, Advanced Lung Disease Trial in United States (Lumacaftor, Ivacaftor)
Completed
- Cystic Fibrosis
- Advanced Lung Disease
- Lumacaftor
- Ivacaftor
-
Denver, Colorado
- +5 more
Oct 31, 2017